Anterix (ATEX) EBITDA US GAAP (year values)

FY2023 FY2024 FY2025 FY2026 FY2026   LTM ? CAGR 5 years ?
EBITDA, bln rub ? -53.4 -51.6 -48.5 -41.2 -41.2   -41.3  
Changes by years, y/y, % +15% -3% -6% -15% 0%     -2.7%

Anterix. EBITDA US GAAP, bln rub

Anterix. EBITDA US GAAP, changes, %

Anterix. EBITDA US GAAP, sum by quarters, bln rub

Anterix (ATEX) EBITDA US GAAP (quarter values)

FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q4 FY2027Q1   LTM ?
EBITDA, bln rub ? -9.51 -9.63 20.4 20.4 0.715   -41.3
Changes by years, y/y, % -27% -4% -294% -294% -106%    
Changes by quarters, q/q, % -18% +1% -312% 0% -96%    

Anterix. EBITDA US GAAP, bln rub

Anterix. EBITDA US GAAP, changes, y/y, %

Anterix. EBITDA US GAAP, changes, q/q, %